155 related articles for article (PubMed ID: 37460202)
1. Performance of the eHealth decision support tool, MIPOGG, for recognising children with Li-Fraumeni, DICER1, Constitutional mismatch repair deficiency and Gorlin syndromes.
Hebert R; Cullinan N; Armstrong L; Blood KA; Brossard J; Brunga L; Cacciotti C; Caswell K; Cellot S; Coltin H; Deyell RJ; Felton K; Fernandez CV; Fleming AJ; Gibson P; Hammad R; Jabado N; Johnston DL; Lafay-Cousin L; Larouche V; Leblanc-Desrochers C; Michaeli O; Perrier R; Pike M; Say J; Schiller I; Toupin AK; Vairy S; van Engelen K; Waespe N; Villani A; Foulkes WD; Malkin D; Reichman L; Goudie C
J Med Genet; 2023 Nov; 60(12):1218-1223. PubMed ID: 37460202
[TBL] [Abstract][Full Text] [Related]
2. Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes.
Goudie C; Witkowski L; Cullinan N; Reichman L; Schiller I; Tachdjian M; Armstrong L; Blood KA; Brossard J; Brunga L; Cacciotti C; Caswell K; Cellot S; Clark ME; Clinton C; Coltin H; Felton K; Fernandez CV; Fleming AJ; Fuentes-Bolanos N; Gibson P; Grant R; Hammad R; Harrison LW; Irwin MS; Johnston DL; Kane S; Lafay-Cousin L; Lara-Corrales I; Larouche V; Mathews N; Meyn MS; Michaeli O; Perrier R; Pike M; Punnett A; Ramaswamy V; Say J; Somers G; Tabori U; Thibodeau ML; Toupin AK; Tucker KM; van Engelen K; Vairy S; Waespe N; Warby M; Wasserman JD; Whitlock JA; Sinnett D; Jabado N; Nathan PC; Shlien A; Kamihara J; Deyell RJ; Ziegler DS; Nichols KE; Dendukuri N; Malkin D; Villani A; Foulkes WD
JAMA Oncol; 2021 Dec; 7(12):1806-1814. PubMed ID: 34617981
[TBL] [Abstract][Full Text] [Related]
3. Retrospective evaluation of a decision-support algorithm (MIPOGG) for genetic referrals for children with neuroblastic tumors.
Goudie C; Cullinan N; Villani A; Mathews N; van Engelen K; Malkin D; Irwin MS; Foulkes WD
Pediatr Blood Cancer; 2018 Dec; 65(12):e27390. PubMed ID: 30117275
[TBL] [Abstract][Full Text] [Related]
4. Nervous system (NS) Tumors in Cancer Predisposition Syndromes.
Patil P; Pencheva BB; Patil VM; Fangusaro J
Neurotherapeutics; 2022 Oct; 19(6):1752-1771. PubMed ID: 36056180
[TBL] [Abstract][Full Text] [Related]
5. Utility of a Cancer Predisposition Screening Tool for Predicting Subsequent Malignant Neoplasms in Childhood Cancer Survivors.
Cullinan N; Schiller I; Di Giuseppe G; Mamun M; Reichman L; Cacciotti C; Wheaton L; Caswell K; Di Monte B; Gibson P; Johnston DL; Fleming A; Pole JD; Malkin D; Foulkes WD; Dendukuri N; Goudie C; Nathan PC
J Clin Oncol; 2021 Oct; 39(29):3207-3216. PubMed ID: 34383599
[TBL] [Abstract][Full Text] [Related]
6. Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high incidence of cancer prone syndromes.
Byrjalsen A; Hansen TVO; Stoltze UK; Mehrjouy MM; Barnkob NM; Hjalgrim LL; Mathiasen R; Lautrup CK; Gregersen PA; Hasle H; Wehner PS; Tuckuviene R; Sackett PW; Laspiur AO; Rossing M; Marvig RL; Tommerup N; Olsen TE; Scheie D; Gupta R; Gerdes AM; Schmiegelow K; Wadt K
PLoS Genet; 2020 Dec; 16(12):e1009231. PubMed ID: 33332384
[TBL] [Abstract][Full Text] [Related]
7. An eHealth decision-support tool to prioritize referral practices for genetic evaluation of patients with Wilms tumor.
Cullinan N; Villani A; Mourad S; Somers GR; Reichman L; van Engelen K; Stephens D; Weksberg R; Foulkes WD; Malkin D; Grant R; Goudie C
Int J Cancer; 2020 Feb; 146(4):1010-1017. PubMed ID: 31286500
[TBL] [Abstract][Full Text] [Related]
8. Imaging of cancer predisposition syndromes in children.
Monsalve J; Kapur J; Malkin D; Babyn PS
Radiographics; 2011; 31(1):263-80. PubMed ID: 21257945
[TBL] [Abstract][Full Text] [Related]
9. Functional Repair Assay for the Diagnosis of Constitutional Mismatch Repair Deficiency From Non-Neoplastic Tissue.
Shuen AY; Lanni S; Panigrahi GB; Edwards M; Yu L; Campbell BB; Mandel A; Zhang C; Zhukova N; Alharbi M; Bernstein M; Bowers DC; Carroll S; Cole KA; Constantini S; Crooks B; Dvir R; Farah R; Hijiya N; George B; Laetsch TW; Larouche V; Lindhorst S; Luiten RC; Magimairajan V; Mason G; Mason W; Mordechai O; Mushtaq N; Nicholas G; Oren M; Palma L; Pedroza LA; Ramdas J; Samuel D; Wolfe Schneider K; Seeley A; Semotiuk K; Shamvil A; Sumerauer D; Toledano H; Tomboc P; Wierman M; Van Damme A; Lee YY; Zapotocky M; Bouffet E; Durno C; Aronson M; Gallinger S; Foulkes WD; Malkin D; Tabori U; Pearson CE
J Clin Oncol; 2019 Feb; 37(6):461-470. PubMed ID: 30608896
[TBL] [Abstract][Full Text] [Related]
10. Updates on progress in cancer screening for children with hereditary cancer predisposition syndromes.
Rednam SP
Curr Opin Pediatr; 2019 Feb; 31(1):41-47. PubMed ID: 30531401
[TBL] [Abstract][Full Text] [Related]
11. Genetic predisposition in children with cancer - affected families' acceptance of Trio-WES.
Brozou T; Taeubner J; Velleuer E; Dugas M; Wieczorek D; Borkhardt A; Kuhlen M
Eur J Pediatr; 2018 Jan; 177(1):53-60. PubMed ID: 28929227
[TBL] [Abstract][Full Text] [Related]
12. High Prevalence of Hereditary Cancer Syndromes in Adolescents and Young Adults With Colorectal Cancer.
Mork ME; You YN; Ying J; Bannon SA; Lynch PM; Rodriguez-Bigas MA; Vilar E
J Clin Oncol; 2015 Nov; 33(31):3544-9. PubMed ID: 26195711
[TBL] [Abstract][Full Text] [Related]
13. Constitutional mismatch repair deficiency as a differential diagnosis of neurofibromatosis type 1: consensus guidelines for testing a child without malignancy.
Suerink M; Ripperger T; Messiaen L; Menko FH; Bourdeaut F; Colas C; Jongmans M; Goldberg Y; Nielsen M; Muleris M; van Kouwen M; Slavc I; Kratz C; Vasen HF; BrugiŃres L; Legius E; Wimmer K
J Med Genet; 2019 Feb; 56(2):53-62. PubMed ID: 30415209
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic Strategies and Algorithms for Investigating Cancer Predisposition Syndromes in Children Presenting with Malignancy.
Rossini L; Durante C; Bresolin S; Opocher E; Marzollo A; Biffi A
Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35954404
[TBL] [Abstract][Full Text] [Related]
15. Current and Emerging Roles of Whole-Body MRI in Evaluation of Pediatric Cancer Patients.
Gottumukkala RV; Gee MS; Hampilos PJ; Greer MC
Radiographics; 2019; 39(2):516-534. PubMed ID: 30681900
[TBL] [Abstract][Full Text] [Related]
16. Predisposition to pediatric and hematologic cancers: a moving target.
Malkin D; Nichols KE; Zelley K; Schiffman JD
Am Soc Clin Oncol Educ Book; 2014; ():e44-55. PubMed ID: 24857136
[TBL] [Abstract][Full Text] [Related]
17. Clinicians Practicing Obstetrics and Gynecology Are Uniquely Situated to Recognize DICER1 Syndrome.
Hayes KG; French AV
J Pediatr Adolesc Gynecol; 2021 Dec; 34(6):780-782. PubMed ID: 34284081
[TBL] [Abstract][Full Text] [Related]
18. Hereditary Cancer Syndromes: A Comprehensive Review with a Visual Tool.
Garutti M; Foffano L; Mazzeo R; Michelotti A; Da Ros L; Viel A; Miolo G; Zambelli A; Puglisi F
Genes (Basel); 2023 Apr; 14(5):. PubMed ID: 37239385
[TBL] [Abstract][Full Text] [Related]
19. Homozygous germ-line mutation of the PMS2 mismatch repair gene: a unique case report of constitutional mismatch repair deficiency (CMMRD).
Ramchander NC; Ryan NA; Crosbie EJ; Evans DG
BMC Med Genet; 2017 Apr; 18(1):40. PubMed ID: 28381238
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic criteria for constitutional mismatch repair deficiency (CMMRD): recommendations from the international consensus working group.
Aronson M; Colas C; Shuen A; Hampel H; Foulkes WD; Baris Feldman H; Goldberg Y; Muleris M; Wolfe Schneider K; McGee RB; Jasperson K; Rangaswami A; Brugieres L; Tabori U
J Med Genet; 2022 Apr; 59(4):318-327. PubMed ID: 33622763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
